The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

DexCom Inc

Nasdaq: DXCM
Last

(U.S.) $62.60

Today's change-2.88 -4.40%
Updated December 7 11:51 AM EST. Delayed by at least 15 minutes.
 

DexCom Inc

Nasdaq: DXCM
Last

(U.S.) $62.60

Today's change-2.88 -4.40%
Updated December 7 11:51 AM EST. Delayed by at least 15 minutes.

DexCom Inc down (U.S.)$2.88

DexCom Inc is sharply lower today, dropping (U.S.)$2.88 or 4.40% to (U.S.)$62.60. Over the last five days, shares have lost 4.12% and are down 23.57% for the last year to date. This security has underperformed the S&P 500 by 34.92% during the last year.

Key company metrics

  • Open(U.S.) $65.00
  • Previous close(U.S.) $65.48
  • High(U.S.) $65.69
  • Low(U.S.) $62.09
  • Bid / Ask(U.S.) $62.57 / (U.S.) $62.63
  • YTD % change-23.57%
  • Volume294,854
  • Average volume (10-day)1,584,804
  • Average volume (1-month)1,579,804
  • Average volume (3-month)1,060,651
  • 52-week range(U.S.) $47.92 to (U.S.) $96.38
  • Beta0.52
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.68
Updated December 7 11:51 AM EST. Delayed by at least 15 minutes.
S&P TSX0.41%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue149137116131
Total other revenue--------
Total revenue149137116131
Gross profit101867591
Total cost of revenue48524140
Total operating expense167157135129
Selling / general / administrative76696261
Research & development44363229
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-19-20-192
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax-19-20-192
Income after tax-19-20-192
Income tax, total00--0
Net income-19-20-192
Total adjustments to net income--------
Net income before extra. items-19-20-192
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-19-20-192
Inc. avail. to common incl. extra. items-19-20-192
Diluted net income-19-20-192
Dilution adjustment------0
Diluted weighted average shares84848282
Diluted EPS excluding extraordinary itemsvalue per share-0.22-0.24-0.230.02
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share-0.22-0.24-0.230.02